• Beta-Cell Dysfunction: A Driver of T2D?

  • Nov 29 2021
  • Duración: 11 m
  • Podcast

Beta-Cell Dysfunction: A Driver of T2D?  Por  arte de portada

Beta-Cell Dysfunction: A Driver of T2D?

  • Resumen

  • What do you know about the role of beta-cell dysfunction in the pathophysiology of type 2 diabetes (T2D)? Join primary care experts in T2D: Dr. John Anderson, Dr. Stephen Brunton and Dr. James LaSalle as we discuss the beta-cell function and its critical role in T2D pathogenesis, what clinicians know or should know about it and how it is measured in the clinic, and how our current knowledge of beta-cell function in T2D may affect future research on T2D treatment.

    This podcast is sponsored by Novo Nordisk and is intended for clinicians. The opinions expressed are those of the speakers and not Novo Nordisk.

    Faculty Presenters:

    John E. Anderson, MD
    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

    Stephen Brunton, MD, FAAFP
    Executive Director
    Primary Care Metabolic Group
    Winnsboro, South Carolina

    James LaSalle, DO, FAAFP
    Medical Arts of Excelsior Springs, Inc.
    Excelsior Springs, Missouri

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Beta-Cell Dysfunction: A Driver of T2D?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.